Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,750.00
-80.00 (-1.17%)
At close: Sep 16, 2025
-1.17%
Market Cap58.23B
Revenue (ttm)71.00B
Net Income (ttm)1.85B
Shares Out8.63M
EPS (ttm)184.24
PE Ratio36.64
Forward PEn/a
Dividend97.68 (1.43%)
Ex-Dividend DateDec 27, 2024
Volume23,861
Average Volume28,076
Open6,800.00
Previous Close6,830.00
Day's Range6,740.00 - 6,900.00
52-Week Range5,988.04 - 10,149.38
Beta1.04
RSI45.21
Earnings DateNov 13, 2025

About Seoulin Bioscience

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd. was founded in 1984 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1984
Employees 104
Stock Exchange KOSDAQ
Ticker Symbol 038070
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.